The global demand for Cord Blood Banking Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Cord blood banking is a process of collecting, potentially extracting, and cryogenically freezing its stem cells and other cells of the immune system and storing them for future use. Stem cells are immature cells that can assume the form of other cells. These cells help the body re-generate tissues and systems; cord blood is often termed regenerative medicine. This makes cord blood at the time of delivery a rich source of stem cells and other immune system cells. They can treat cancer, blood diseases like anemia, and some immune system disorders, which disrupt the body's ability to defend itself.
Market Dynamics
Cord blood banking is gaining robust popularity with the emergence of regenerative medicine. The rising burden of diseases such as cancer, blood diseases, and immune system disorders and growing advancement in regenerative medicine drive the global cord blood banking market. Cord blood has an abundance of stem cells and immune system cells, and the medical use of these cells has been expanding at a rapid pace. Cord blood is currently approved by the FDA to treat nearly 80 diseases and is under process to support more. Researchers are exploring cure mechanisms, which may be instrumental in treating other conditions that have been untreatable up to this point. This may create new market opportunities. However, cord blood banking has some cons that may impede its widespread growth, including low awareness and the high cost of the process.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cord blood banking. The growth and trends of cord blood banking industry provide a holistic approach to this study.
Market Segmentation
This section of the cord blood banking market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Services
- Processing
- Storage
- Others
By Application
- Cancer
- Blood Disorders
- Immuno-Deficiency Disorders
- Metabolic Disorders
- Bone Marrow Failure Syndrome
- Others
By End-Use
- Hospitals
- Research Institutes
- Specialty Clinics
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Cord Blood Banking market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Cord Blood Banking Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cord blood banking market include Cordlife, Singapore Cord Blood Bank, ViaCord LLC, CBR Systems, FamiCord, Cryo-Save, Americord, LifeCell, Global Cord Blood Corporation, Jeevan Stem Cell Foundation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.